Abbott Could Lose $2.2 Billion This Year! Mainly Pressured by the Chinese and American Markets

On April 16th, global medical device giant Abbott disclosed in a financial report conference call that it expects this year's tariff policies to have an impact of "several hundred million dollars" on the company. Although Abbott did not provide details of the tariff costs, Vijay Kumar, an analyst at the globally renowned investment bank Evercore ISI, estimates that this year's tariffs will bring about $300 million to Abbott. (approximately RMB2.2 billion coinsNegative effects.Among them, the US and Chinese markets will be the main pressure zones. Reuters reported that,China is a major source of raw materials for the pharmaceutical and medical device industries.